BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 26
• 27
• 28
• 31

• Drug Development

  Neuro-Hitech, Inc. Announces Completion of Double-Blind Part of Phase Two Clinical Trial of Huperzine A in Alzheimer’s Disease

  December 14, 2007

   · 

  1 min read
• Business

  UCB Group on Track

  December 14, 2007

   · 

  1 min read
• Business

  Changes in UCB Group’s Board of Directors

  December 14, 2007

   · 

  1 min read
• Business

  BioSyent Inc. Management Announcement

  December 14, 2007

   · 

  1 min read
• Business

  Cleveland Biolabs Inc. Recaps Development of Lead Compounds and Affirms Confidence in Competitive Position for Department of Defense Contract

  December 14, 2007

   · 

  1 min read
• Drug Development

  Adolor Corporation Initiates Phase 2a Study of Delta Agonist ADL5859 in Neuropathic Pain

  December 14, 2007

   · 

  1 min read
• Business

  Alnylam Pharmaceuticals Appoints Barry Greene President and Chief Operating Officer

  December 14, 2007

   · 

  1 min read
• Genetown

  Javelin Pharmaceuticals Dyloject(R) Added to Hospital Formulary in UK

  December 14, 2007

   · 

  1 min read
• Pharm Country

  OSI Pharmaceuticals, Inc. Announces Launch Date of Tarceva(R) (erlotinib) in Japan

  December 14, 2007

   · 

  1 min read
• Drug Development

  Inhibitex, Inc. Reports Favorable Results from First Clinical Trial of FV-100

  December 14, 2007

   · 

  1 min read